Jette Johansen Novo Nordisk

Jette has 30 years of experience within the pharma industry, mainly within the quality area, with a special interest in the transfer of products from development to commercial phase including process validation and across drugs substance and drug products, small molecules and biotechnology, raw materials, and assembly and packaging processes. Jette has always had a special interest in GMP guidelines. From that perspective, Jette has been working with interpreting new guidelines, and the process of providing comments on behalf of Novo Nordisk and industry organizations. Jette has been a PDA member for many years and has now taken up the challenge of being a member of the 2022 Quality and Regulations Conference committee.